This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Genetics  • Genetic Disorders  • Alert me on articles by topic

Apolipoprotein E 4 Count Affects Age at Onset of Alzheimer Disease, but Not Lifetime Susceptibility

The Cache County Study

Ara S. Khachaturian, PhD; Christopher D. Corcoran, PhD; Lawrence S. Mayer, MD; Peter P. Zandi, PhD; John C. S. Breitner, MD; for the Cache County Study Investigators

Arch Gen Psychiatry. 2004;61:518-524.

Background  The incidence of Alzheimer disease (AD) increases strongly with age, but little is known about the cumulative incidence of AD over a lifetime of 100 years, or its relationship to the polymorphic APOE locus that encodes apolipoprotein E. APOE is a strong genetic risk factor for AD

Objectives  To estimate the occurrence of AD as a function of age and number of APOE 4 alleles; and to explore evidence for heterogeneity of AD risk related toAPOE genotype and to other sources.

Design  Nonparametric and parametric survival analyses of AD incidence in prospective longitudinal study.

Setting and Participants  A total of 3308 elderly residents of Cache County, Utah.

Main Outcome Measures  Cumulative incidence of AD; in mixture models assuming susceptible and nonsusceptible individuals, the proportion of individuals not susceptible to AD at any age.

Results  Models that assumed a proportion of invulnerable individuals provided strongly improved fit to the data. These models estimated the 100-year lifetime incidence of AD at 72%, implying that 28% of individuals would not develop AD over any reasonable life expectancy. We confirmed the acceleration of AD onset in individuals with 1 or, especially, 2 APOE, 4 allelesbut observed no meaningful difference in 100-year lifetime incidence related to number of 4 alleles.

Conclusions  The APOE 4 allele acts as a potent risk factor for AD by accelerating onset. However, the risk of AD appears heterogeneous in ways independent of APOE.Some individuals seem destined to escape AD, even over an extended lifespan. Their relative invulnerability may reflect other genes or environmental factors that can be investigated.

From Khachaturian and Associates Inc, Potomac, Md (Dr Khachaturian); Center for Epidemiologic Studies and Department of Mathematics, Utah State University, Logan (Dr Corcoran); Alzheimer's Research Center, Banner Good Samaritan Medical Center, Phoenix, Ariz (Dr Mayer); Department of Mental Health, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Md (Drs Mayer, Zandi, and Breitner); Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Healthcare System, Seattle, Wash (Dr Breitner); and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Dr Breitner).